In Depth 25 Dec 2024
When biotech makes Christmas miracles a reality
Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future.
- Latest Posts
Best in Biotech 23 Dec 2024
The best biotech movies to watch this winter
Dive into the world of biotech cinema this holiday season! Our list of biotech movies offers the perfect blend of science and entertainment.
Podcast 20 Dec 2024
Looking at 2025 biotech trends with SoftBank Vision Fund
In our discussion with John Cassidy from SoftBank Vision Fund, we cover investment trends within life sciences, the European health and biotech scene
In Depth 19 Dec 2024
After decades of stagnation, is Japan’s biopharma industry set for an upswing?
Discover the history of Japan’s biopharma industry and whether it is now set for an upswing after years of stagnation from economic troubles.
In Depth 18 Dec 2024
AI + CRISPR: The explosive fusion that will redefine biotechnology
With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration.
In Depth 17 Dec 2024
Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic
A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 16 Dec 2024
10 biotech companies to watch in 2025
As 2025 is expected to be an exciting year for the biopharma industry, discover ten biotech companies to keep an eye on in 2025.
In Depth 13 Dec 2024
Is China the future of biotech?
Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context.
Podcast 13 Dec 2024
Finding new treatments for peanut allergy
Individuals with peanut allergies are at constant risk of severe reactions, and this week, we talk about new treatments with Jessica Grossman of IgGenix.
News and Trends 12 Dec 2024
Top biotech deals of November 2024
November has seen a variety of biotech deals take place to advance therapies across different stages in development.
In Depth 11 Dec 2024
Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?
Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.
Antibody Therapy R&D trends and breakthrough innovations
Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart.
ADVERTISEMENT
